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The clinical consequence of chronic Pseudomonas aeruginosa colonization in cystic fibrosis (CF) varies between individuals for unknown
reasons. Auto-antibodies against bactericidal/permeability increasing protein (BPI-ANCA) are associated with poor prognosis in CF. We
hypothesize that there is a correlation between the presence of BPI-ANCA, the properties of the colonizing bacteria and the clinical conditions of
the host. We compared isolates of P. aeruginosa from BPI-ANCA positive CF patients who have deteriorating lung disease with BPI-ANCA
negative CF patients who are in stable clinical conditions. Epithelial cells (A549) and isolated polymorphonuclear granulocytes (PMNs) were
stimulated with the isolates and cell death was analyzed with flow cytometry. We found that the ANCA associated strains in most cases showed
pyocyanin negative phenotypes. These strains also induced less inflammatory response than the non-ANCA associated strains as shown by
apoptosis and necrosis of epithelial cells and neutrophils. Our results suggest that colonization with strains of P. aeruginosa that induce a weak
inflammatory response is associated with unfavorable outcome in CF. We speculate that inadequate control of pathogen proliferation through an
insufficient inflammatory response results in a slowly increasing number of bacteria and accumulation of dying PMNs in the airways, contributing
to progression in CF lung disease.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: BPI-ANCA; Pseudomonas aeruginosa; Chronic colonization; Neutrophils; Pyocyanin; Interleukin 8; Anti-neutrophil cytoplasmic antibodies; Apoptosis1. Introduction
In cystic fibrosis (CF), bacterial colonization of the airways
with an accompanying destructive inflammatory process is a
major cause of death. The predominant pathogens isolated from
CF patients have been Staphylococcus aureus, Haemophilus
influenzae and Pseudomonas aeruginosa. The presence of S.
aureus usually precedes colonization with P. aeruginosa and
the establishment of a chronic colonization is considered an
important hallmark for poor prognosis [1].
P. aeruginosa colonization in CF is a unique model for long-
term host–pathogen interaction, as the colonization lasts for⁎ Corresponding author. Tel.: +46 46 2220701; fax: +46 46 2220748.
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doi:10.1016/j.jcf.2011.03.004years or decades, with slowly increasing tissue damage and no
resolution of the inflammation. The majority of patients who
become chronically colonized indeed deteriorate in their lung
disease. Yet some patients are chronically colonized for years
without developing any serious lung damage. This discrepancy
in the disease development is partly explained by the CF
transmembrane regulator (CFTR) genotypes [2] but is otherwise
still largely unexplained.
Chronic colonization heralds several phenotypic changes in
the P. aeruginosa like change from non mucoid to mucoid
phenotype, alginate production, biofilm formation and use of
quorum sensing. P. aeruginosa is well known to exhibit ad by Elsevier B.V. All rights reserved.
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host defense [3–7]. It has been shown that serially collected
strains of P. aeruginosa from CF patients induce different
responses in epithelial cells in the early and late stage of the
colonization [6].
In CF, large numbers of apoptotic and necrotic PMNs are
present in the airways, possibly showing that the phagocytic
mechanisms are overwhelmed [8,9]. Specific bacterial char-
acteristics, such as alginate production and the ability to induce
cytokine release, are known to influence the apoptosis rate of
PMNs and epithelial cells [10,11]. One well-described P.
aeruginosa virulence factor is pyocyanin, which is a phenazine
derivative that in combination with the fluorescent siderophore
pyoverdine results in a green phenotype when grown on agar
[12]. Pyocyanin is known to interact with PMNs and epithelial
cells. Acceleration of PMN apoptosis by pyocyanin is well
known and the mechanism for this process was recently
described [13,14]. Furthermore it was shown that phagocytosis
of apoptotic cells was impaired when the macrophages were
treated with pyocyanin [15] Pyocyanin is also known to induce
IL-8 expression in epithelial cells in vitro [16].
Anti-neutrophil cytoplasmic antibodies (ANCA) are auto-
antibodies directed against proteins located in the granula of
PMNs. BPI-ANCA is the denomination of autoantibodies
directed against the granula protein bactericidal/permeability
increasing protein (BPI), which is a 55 kD protein essential for
the control of Gram negative infection. BPI is able to bind to
and neutralize lipopolysaccharides [17]. It also has opsonizing
and directly bacteriolytic properties [18]. Approximately 50%
of CF have elevated serum levels of autoantibodies directed
against BPI (BPI-ANCA) [17,19–24]. Data from our group
showed a strong correlation between BPI-ANCA and P.
aeruginosa colonization. Moreover, among the P. aeruginosa
colonized patients, elevated levels of BPI-ANCA predicted a
poor outcome [25], indicating that BPI-ANCA differentiates
between harmful and less harmful colonization. This led us to
speculate that isolates of P. aeruginosa from BPI-ANCA
positive patients differ in their interaction with host cells
compared to isolates from BPI-ANCA negative patients.
In this study isolates of P. aeruginosa from two well defined
groups of CF patients were compared; one with positive serum
levels of BPI-ANCA, known to be associated with poor
prognosis, and one with negative BPI-ANCA where most
patients had stable clinical conditions. All patients had a long
history of P. aeruginosa colonization. Our aim was to
investigate the isolates from the two groups in their interactions
with epithelial cells and with isolated PMNs, in order to
evaluate if there is a correlation between bacterial properties and
the appearance of BPI-ANCA.
2. Material and methods
2.1. Patients
CF patients who had been chronically colonized with P.
aeruginosa for at least three years were identified for the study.
The BPI-ANCA of the IgA isotype in serum was measured in allpatients at the CF Centre, Lund University Hospital, by enzyme
linked immunosorbent assay (ELISA) as was previously
described [20,26]. A cut-off level differentiating between BPI-
ANCA positive and BPI-ANCA negative sera, was defined to
be 67 U/L by using the mean value of 40 healthy controls
+3SD. Negative sera BPI-ANCA are rare in patients with a long
history of P. aeruginosa, however, nine such patients were
identified, all with fairly stable clinical conditions. As controls,
twelve patients were identified, all with high serum levels of
BPI-ANCA, most with progressive lung disease. Chronic
colonization was defined according to European consensus,
i.e. three consecutive positive cultures [27]. In patients
colonized with more than one strain, the first identified non-
mucoid strain was chosen. The study was approved by the local
research ethics committee.2.2. Isolates of P. aeruginosa
All P. aeruginosa isolates from CF patients cultured for
clinical purposes at the department of Clinical Microbiology
and Immunology at Lund University Hospital were kept at
−80 °C. Species identification was based on colony morphol-
ogy, oxidase test, growth on cetrimide agar at 42 °C and
arginine dihydrolase production [12]. Isolates with an atypical
phenotype were subjected to 16S rDNA sequence analysis. The
reference strain PAO1 was included in all experiments. Strains
with a non-mucoid phenotype were preferably included in the
present study. The non-mucoid phenotype facilitated that the
number of CFU, in each test was equivalent for all strains, was
established in an easy and accurate way what most probably
would not have achieved with the highly mucoid phenotypes.
All isolates were subjected to genomic fingerprinting using
pulsed-field gel electrophoreses (PFGE) in order to establish the
relation between the studied isolates. The PFGE was carried out
by Ewa Johansson at Microbiology laboratory, Sahlgrenska
University Hospital, Gothenburg, Sweden.2.3. Culture and preparation of isolates
The thawed bacteria were grown for 17–19 h on ISO-
sensitest agar (Oxoid, UK) at 35–37 °C. From this primary agar
plate a single colony from each strain was spread out on ISO-
sensitest agar, King A and King B plates to give a confluent
growth and incubated for 17–19 h. The following day, the
growth on ISO-sensitest and King A agar was inspected for
green pigmentation, indicating a production of pyocyanin and
pyoverdine [28]. Growth on King B agar was inspected for
fluorescence under UV light, indicating pyoverdine production.
The swarming activity was tested in 0.5% agar (Blood agar
base, Oxoid, Basingstoke, UK) supplemented with 0.25% beef
extract (Lab Lemco Powder, Oxoid), 0.19% yeast extract
(Difco, BD) and 0.4% Bacto Pepton (Becton Dickinson AB,
Stockholm, Sweden). Bacteria were spotinoculated onto the
agar taken directly from overnight cultures. Plates were
incubated at 30 °C for 24 h and thereafter at room temperature
for another 24 h.
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structures and human cells, a whole cell bacteria preparation was
made. The confluent growth from one agar plate was harvested in
phosphate buffered saline (PBS) and washed three times. The
pellet was suspended in 10 ml of PBS. This suspension was used
as stock solution and the number of bacteria was estimated to be
1010 colony forming units (CFU)/ml, confirmed by viable count.
The number of cells was in all cases found correct within
reasonable limits (0.7–30∗1010 CFU/ml, no group bias). The
stock solution was serially diluted in L-glutamine-containing
RPMI 1640 medium (PAA laboratories, Pasching, Austria)
supplemented with Gentamicin 10 μg/ml and 10% fetal calf
serum (FCS) (GIBCO, Invitrogen, Paisley, UK) to give densities
of approximately 109, 108, 107 106 and 105 CFU/ml.
To study the interactions between human cells and proteins
released from bacteria during overnight growth in Luria-Bertani
medium (LB), supernatants were prepared for cell stimulation.
To obtain the bacterial supernatants, a single colony from the
primary agar plate was suspended in 50 ml LB and incubated
with shaking for 17–19 h at 35–37 °C. The absorbance of the
culture was constantly measured. When the cells reach 0.8–1.0
absorbance bacterial cells were spun down and the supernatant
was collected after filtration through a 0.2 μm filter (Sartorius,
Goettingen, Germany).
2.4. Pyocyanin assay
Bacteria were grown overnight in LB media as above, and
centrifuged at 6000×g for 10 min at room temperature and the
supernatant was collected after filtration through a 0.2 μm filter
(Sartorius,). A 5.0 ml portion of the bacteria supernatants was
mixed with 3 ml chloroform. After centrifugation for 3 min at
1200×g at room temperature, 2.5 ml of the under chloroform
phase were collected and mixed with 1 ml 0.2 M HCL. Samples
of 200 μl were transferred in duplicates to an ELISA plate and the
absorbance measured at 530 nm in a spectrophotometer [29].
2.5. Cell culture
The human alveolar epithelial-like lung carcinoma cell line
A549 was cultured in 75 cm2 tissue culture flasks (Nunc,
Roskilde, Denmark) at 37 °C with 5% CO2. RPMI with
Gentamicin and FCS was used as culture medium. When
passaging the cells, PBS 0.02% EDTA was used for detachment.
2.6. Stimulation of A549 epithelial cells
The cells were plated onto 6-well plates, 3.5–4×105 cells/
well, and cultured overnight until they reached an approximately
80% confluency. Before the experiment the cells were washed
with PBS. Bacteria suspended in 2 mlRPMIwithGentamicin and
FCS as described above at approximate densities of 109, 107, 106
and 105 CFU/ml were added. Cells were also stimulated with
bacterial supernatant diluted to 5 and 20% in RPMI with
Gentamicin and FCS. All stimulations were performed in
duplicates and two control wells with no stimulation were run
in each experiment. Cells were incubated at 37 °C for 20–22 h.Before cells were harvested, supernatants were collected for IL-
8 measurement. Cells were washed with PBS and detached using
0.02% EDTA in PBS, spun down and resuspended in 100 μl of
RPMI with Gentamicin. All experiments were performed twice
with similar results.
2.7. Isolation of PMNs
PMNs were isolated from human blood kindly provided by
four healthy volunteers. As described by the manufacturer, the
whole blood from EDTA-anti-coagulated tubes was carefully
layered on Polymorphprep™ (Axis-Shield PoC AS, Oslo,
Norway) and centrifuged at 625×g for 30 min at room
temperature. The PMN layer was recovered and suspended in
0.45% NaCl and RPMI with Gentamicin before pelleting the
cells at 250 × g for 10 min at room temperature. Contaminating
erythrocytes were removed by hypotonic lysis for 7 min at
37 °C using 0.83% NH4Cl in 10 mM Hepes, pH 7.0. The cells
were then pelleted at 250 x g for 5 min at room temperature and
resuspended in RPMI with Gentamicin. The percentage of
PMNs was 95–99%, as determined by Türk staining. Viability,
checked using Trypan Blue staining, was N95%.
2.8. Stimulation of PMNs
Tubes containing 106 PMNs and 200 μl bacterial supernatant
mixed with 800 μl RPMI with Gentamicin were incubated
within 1 h after isolation of the PMNs for 18–20 h at 37 °C
rotating. Before analysis the cells were spun down and
resuspended in 100 μl RPMI with Gentamicin.
2.9. Flow cytometry investigation of epithelial cells and PMNs
Apoptotic and necrotic cells were demonstrated by double
staining using 5 μl annexinV-Alexa Fluor® 488 (Molecular
Probes™) and 20 μl BD Via-Probe™ (BD Pharmingen
Biosciences) for 15 min in the dark. Flow cytometry analysis
was performed using an EPICS XL-MCL Coulter System 2
flow cytometer. The PMN population and the epithelial cell
population were selected by gating with appropriate settings for
forward scatter (FSC) and sideward scatter (SSC). The FL1
fluorescence channel was used to record the emitted fluores-
cence from Alexa fluor 488 and the FL3 fluorescence channel
was used for Via-Probe. For each condition, cells were collected
until 20,000 gated events were acquired or the time limit 300 s
was reached. Acquisition and analysis of the data was
performed using the System 2 software. Cells positive for
annexin V only are from now on denominated as apoptotic and
all cells positive for BD Via-Probe as necrotic, including double
positive cells.
2.10. ELISA for IL-8
The concentrations of IL-8 in A549 cell stimulation super-
natants weremeasured by ELISA according to themanufacturer’s
description (R&D systems). In short, mouse anti-human CXCL8/
IL-8 monoclonal antibodies at a concentration of 1 μg/ml were
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cold overnight, then the wells were emptied and block solution
added for one hour and the wells washed three times. Samples
were added and incubated for two hours and then washed three
times.Bound IL-8was detected using biotin-conjugated goat anti-
human IL-8 (R&D Systems). IL-8 was quantified from a
calibrator curve of standard solution (R&D Systems) that was
serially diluted, giving detection limits between 31 and 2000 pg/
ml.2.11. Statistics
To compare the medians, the Mann–Whitney test was used
(Figs. 1–3). Fisher's exact test was used when applicable. The
correlation in Fig. 4 was obtained with linear regression.3. Results
3.1. Strains with a green phenotype were mostly found in
BPI-ANCA negative patients
A green phenotype was shown by 10 of the 21 strains when
grown on ISO-sensitest agar, and a significant correlation
between BPI-ANCA positive patients and strains with a white
phenotype, p=0.03, (Fisher's exact test) was obtained (Table 1).
To substantiate our findings, the strains were plated on King A
and King B agar to test for the production of pyocyanin and
pyoverdine, respectively. The green phenotype was once more
shown by 10 strains, and 17 strains were found to be pyoverdine
positive. A few strains showed a yellow or brown phenotype on
KingA agar. Strains that were isolated from patients with positive
serum level of BPI-ANCA (above 67 U/L) are from now on
referred to as ANCA associated strains.
The strains were also typed for genome fingerprinting by
PFGE to confirm that the strains isolated from different patientsCo
ntr
ol
AN
CA
no
t A
NC
A
PA
O1
0
20
40
60
80
100
Live
Pe
rc
en
ta
ge
Co
ntr
ol
AN
CA
no
t A
NC
A
PA
O1
Apoptosis
Co
ntr
p=0.02
p=0.008
A
Fig. 1. A549 epithelial cells stimulated for 20–22 h with 20% bacterial supernatant fro
with 20%LBwere used as controls. Cells were examined concerning apoptosis and nec
by ELISA. A: percentage of living, apoptotic and necrotic (including secondary necros
error of themean. The two-sidedMannWhitney test was used to compare themedians. T
8 release in the epithelial cells compared to the control. No increased induction of cel
however increased compared to the control (p=0.03). Flow cytometry data from one owere not identical. We found 11 different PFGE patterns by the
isolates from BPI-ANCA positive patients and nine different
patterns form the isolates from the BPI-ANCA negative
patients. Three of the BPI-ANCA positive isolates show
identical (AK) or closely related (AK-1) PFGE pattern
(Table 1).
The isolates were characterized further for their swarming
motility and only one isolate from a BPI-ANCA negative patient
showed the swarming motility on semi-solid agar.3.2. ANCA associated strains and cell death in epithelial cells
The epithelial cell line A549 was stimulated with 20%
supernatant from an overnight LB culture of each strain. Cells
were harvested after 20–22 h and analyzed by flow cytometry for
apoptosis and necrosis. We found that the reference strain PAO1
induced more apoptosis and necrosis in A549 cells than the
clinical isolates. ANCA associated strains induced no increase in
cell death compared to control. The strains that were non-ANCA
associated induced a significant apoptosis in epithelial cells
compared to control and ANCA positive isolates, although less
than PAO1 (Fig. 1A).
Stimulation with whole cell bacteria showed an increased
induction of necrosis by all strains, including PAO1 compared
to control. No difference in induced cell death was seen in the
percentages between the ANCA and the non-ANCA associated
strains.3.3. P. aeruginosa induce IL-8 release from A549 cells
A549 cell cultures were stimulated with bacterial supernatants
and the supernatants were collected after stimulation and IL-8was
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Fig. 2. A549 epithelial cells stimulated with P aeruginosa at a concentration of 109 colony forming units/ml for 20–22 h. The ANCA associated strains (n=12) are
Pseudomonas aeruginosa isolated from cystic fibrosis patientswith high levels of IgA-BPI-ANCA in serum, and the non-ANCAassociated strains (n=9)were isolated from
patients with negative IgA-BPI-ANCA. PAO1 is a reference strain and A549 cells grown in RPMI were used as controls. Cells were examined concerning apoptosis and
necrosis with flow cytometry and interleukin 8 (IL-8) was measured in cell supernatant by ELISA. A: percentage of living, apoptotic and necrotic (including secondary
necrosis) cells after stimulation. B: released IL-8 (pg/ml). Bars show mean and standard error of the mean. The two-sided Mann Whitney test was used to compare the
medians. No difference in cell death or IL-8 induction was seen between ANCA and non-ANCA associated isolates. Both non-ANCA and ANCA induced significantly
increased cell death and IL-8 compared to the control. Flow cytometry data from one out of two experiments with similar results are shown.
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PMNs
Isolated PMNs from five different healthy donors were
challenged for 18–20 hwith supernatants from overnight cultures
of PAO1 and the clinical isolates. When analyzed by flow
cytometry after 18–20 h, the PMNs challenged with supernatants
from non-ANCA associated strains showed an accelerated
necrosis rate compared to the controls (Fig. 3). A connection
between necrosis and the green phenotype was shown by a highly
significant correlation between the content of pyocyanin in theCo
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Fig. 3. Isolated polymorpho nuclear granulocytes (PMNs) from four healthy
donors stimulated with 20% bacterial supernatant from an overnight growth in
Luria-Bertani medium (LB). The ANCA associated strains (n=12) are
Pseudomonas aeruginosa isolated from cystic fibrosis patients with high levels
of IgA-BPI-ANCA in serum, and the non-ANCA associated strains (n=9) were
isolated from patients with negative IgA-BPI-ANCA. PAO1 is a reference strain
and PMNs incubated in RPMI were used as control. Cells were examined
concerning apoptosis and necrosis with flow cytometry after overnight stimulation.
The bars show the percentage of living, apoptotic and necrotic (including
secondary necrosis) cells after stimulation. Bars show median and inter-quartile
range. The two-sidedMann–Whitney test was used to compare medians. The non-
ANCA associated strains induced increased necrosis compared to ANCA
associated strains and control.supernatants, as measured by spectrophotometry, and necrosis of
the PMNs (Fig. 4).
4. Discussion
In this investigation we found biological differences between
P. aeruginosa isolated from BPI-ANCA positive, and BPI-
ANCA negative CF patients. BPI-ANCA in CF is associated with
extensive lung damage and poor prognosis [17,19–21,24,25,30].
Paradoxically, the ANCA associated strains were less harmful in
their interaction with epithelial cells in vitro. They induced no
increased cell death and a more discrete increase in IL-8 release
from epithelial cells compared to controls, while the non-ANCA
associated strains induced a more powerful inflammatory
response (Figs. 1 and 2).
We found that the non-ANCA associated strains were
significantly more prone to produce phenazine derivatives as
shown by a green phenotype when grown on agar plates. It wasPyocyanin (arbitrary units)
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Fig. 4. Clinical isolates of Pseudomonas aeruginosa from CF patients were
grown overnight in Luria-Bertani medium (LB). Pyocyanin was measured by
spectrophotometry in the supernatants. Isolated polymorpho nuclear granulo-
cytes from a healthy donor were stimulated with 20% bacterial supernatant.
Cells were examined concerning necrosis with flow cytometry after 20–22 h of
incubation. The correlation for all the samples between induced necrosis and
concentration is shown in the graph, r=0.71, p=0.0001.
Table 1
Pheotypes of P. aeruginosa isolates and corresponding patient data.
CFTR genotype Gender/age BPI-ANCA (U/L) FEV1%
pred
Strain Phenotype
Iso sensitest agar King A pyocyanin King B pyoverdin PFGE
dF508/394delTT F/9 3 94 227D Green/mu- Green – J
175insT/175insT F/15 5 50 156A White/mu- White – DR
dF508/dF508 F/12 8 67 032 Green/mu- Yellow + AA-3b-2
dF508/dF508 F/26 9 89 068C Green/mu- Yellow + EH
dF508/dF508 M/30 10 72 335A Green/mu- Green (+) FM-2
dF508/3659delC M/50 15 44 308B Green/mu- Green + DO-2-2
dF508/dF508 F/24 22 74 24A ⁎⁎ White/mu- White + ET-2
dF508/dF508 M/30 54 65 022A Green/mu- Green + HN
dF508/dF508 F/19 55 76 63A Green/mu- Green + EU
dF508/dF508 F/11 104 97 007 Green/mu- Green – BF
dF508/dF508 F/21 115 59 11A White/mu- Yellow + AK
dF508/dF508 M/11 128 97 005 White/mu- White + AK
dF508/dF508 F/22 138 65 481B White/mu- White + AK-1
dF508/394delTT M/34 153 22 053A White/mu- Yellow + H-3
dF508/dF508 M/43 197 76 039C Green/mu- Green + EK-2-2
dF508/dF508 M/29 377 69 033 White/mu ⁎ Brown + HR
dF508/394delTT M/41 408 33 82B Green/mu- Green + HP
175insT/175insT M/27 535 28 195B White/mu- White + D-4-7-4
dF508/dF508 F/38 762 18 121A White/mu- White + HS
dF508/dF508 F/28 818 18 041E White/mu- White + HO
d508/2183AA–G M/24 888 41 478 White/mu ⁎ White – BA
⁎⁎ Positive swarming test.
⁎ These strain shift between mucoid and non-mucoid phenotype during cultivation.
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influence the rate of apoptosis and necrosis in PMNs [8,10,13,14].
In our experiments, substances released from the non-ANCA
associated strains (mainly with green phenotypes) were potent
inducers of primary necrosis in PMNs, also shown by a dose
response relationship between the pyocyanin concentration in the
supernatant and the necrosis rate induced (Figs. 3 and 4). This
stands in contrast to the substances released from the ANCA
associated strains (mainly white phenotypes) that showed no
increased induction of necrosis in PMNs compared to control.
Genetic adaptation of many bacterial species during chronic
colonization in order to escape host defense is well documented
[3–6]. Smith et al. have found in the whole genome analysis a
strain of P. aeruginosa in a CF patient that underwent numerous
genetic adaptations particularly in virulence factors over a period
of several years [3].
Our results indicate that the ANCAassociated strains are better
adapted to CF lung environment than the non-ANCA associated
strains. In the scenario of an acute inflammation, pathogen
invasion causes a powerful recruitment of inflammatory cells,
limiting the bacterial proliferation. The relatively low pro-
inflammatory response caused by the ANCA associated strains
might explain why these strains manage to proliferate in the
challenging environment of the CF lung [31]. We hypothesize
that these low virulence strains cause a constant but insufficient
influx of inflammatory cells that over the years or decades results
in a slowly increasing bacterial number and chronic inflamma-
tion. It is likely that also the macrophages are influenced by the
properties of the colonizing P. aeruginosa strain, possibly
limiting their phagocytic capacity. Tissue destruction will follow,
as dying PMNs accumulate in the airways, overwhelming the
capacity of the phagocytic cells.We have previously shown that the formation of BPI-ANCA
in CF is strongly correlated to colonization with P. aeruginosa
and extensive lung damage. In this study we have found that the
P. aeruginosa strains isolated from patients with BPI-ANCA
had different biological properties concerning the inflammatory
response. We speculate that this environment of proliferating
bacteria and the accumulation of apoptotic and necrotic PMNs
in the airways underlie the destructive lung disease. Further-
more, this setting might change the interaction between the
bacteria and BPI, leading to the formation of a new epitope,
which may trigger autoantibody responses to BPI. The role of
BPI-ANCA is unclear but it might possibly interfere with BPI
mediated anti-microbiological functions.
There have been reports where a loss of gene or a phenotype/
function has conferred a selective advantage on P. aeruginosa
under certain environmental conditions. De Vos et al. showed
an increase of pyoverdine negative mutants in cystic fibrosis
patients that still had the capacity to take up pyoverdine [32].
Mutants of lasR gene, a quorum-sensing regulator gene were
found to increase as a function of the lung colonization time.
The lasR loss-of-function mutations in these strains conferred a
growth advantage with particular carbon and nitrogen sources,
including amino acids. This growth phenotype may be
responsible for the selection of lasR mutants both on rich
medium and in the CF airway, supporting a key role for
bacterial metabolic adaptation during chronic infection. Inacti-
vation of lasR also resulted in an increased ß-lactamase activity
that increased tolerance to ß-lactam antibiotics [33].
An adequate inflammatory response is crucial for the
elimination of invading pathogens. We have found that CF
patients with unfavorable phenotypes carry strains of P.
aeruginosa with decreased pro-inflammatory properties. We
271M. Carlsson et al. / Journal of Cystic Fibrosis 10 (2011) 265–271suggest that an inadequate control of bacterial proliferation
through insufficient induction of host defense results in a slowly
increasing bacterial load, orchestrating a net influx of inflamma-
tory cells, formation of BPI-ANCA and tissue destruction in CF
airways. Further studies are needed to characterize on a molecular
level which bacterial features that predispose for autoantibody
generation and to what extent these features overlap with an
unfavorable course of the disease.
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